02:34 PM EDT, 08/19/2024 (MT Newswires) -- Liquidia ( LQDA ) said it received tentative US Food and Drug Administration approval for its drug Yutrepia for the treatment of adults with pulmonary arterial hypertension and pulmonary hypertension associated with lung disease but final approval can only be granted after the 2025 expiration of the exclusivity period for United Therapeutics's ( UTHR ) Tyvaso DPI.

Shares sank 32% as intraday trading volume catapulted to more than 13.4 million from a daily average of about 874,000.

Cingulate ( CING ) filed a preliminary prospectus on Monday for the resale of up to 1 million shares by Lincoln Park Capital Fund.

Shares of Cingulate ( CING ) plunged 30%, with intraday trading volume at over 8.25 million versus a daily average of about 3.37 million.

B. Riley Financial ( RILY ) said late Friday that Chair and Co-Chief Executive Bryant Riley made an unsolicited proposal to take the company private for $7 per share.

Shares slid 7.7% as intraday trading volume climbed to over 5.11 million from a daily average of roughly 1.79 million.

Price: 9.56, Change: -4.55, Percent Change: -32.25